These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 313448)

  • 1. Salicylate-induced gastrointestinal bleeding: comparison between soluble buffered, enteric-coated, and intravenous administration.
    Mielants H; Verbruggen G; Schelstraete K; Veys EM
    J Rheumatol; 1979; 6(2):210-8. PubMed ID: 313448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salicylate-induced occult gastrointestinal blood loss: comparison between different oral and parenteral forms of acetylsalicylates and salicylates.
    Mielants H; Veys EM; Verbruggen G; Schelstraete K
    Clin Rheumatol; 1984 Mar; 3(1):47-54. PubMed ID: 6331971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enteric-coated pelletized aspirin. Gastrointestinal blood loss and bioavailability.
    Portek I; Graham G; Fleming A
    Med J Aust; 1981 Jul; 2(1):39-40. PubMed ID: 6974303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of gastrointestinal bleeding in patients with cardiovascular disease: buffered aspirin versus enteric-coated aspirin.
    Hirata Y; Kataoka H; Shimura T; Mizushima T; Mizoshita T; Tanida S; Kamiya T; Joh T
    Scand J Gastroenterol; 2011 Jul; 46(7-8):803-9. PubMed ID: 21501103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal blood loss with low dose (325 mg) plain and enteric-coated aspirin administration.
    Savon JJ; Allen ML; DiMarino AJ; Hermann GA; Krum RP
    Am J Gastroenterol; 1995 Apr; 90(4):581-5. PubMed ID: 7717315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant use of buffered and enteric-coated low-dose aspirin products and antisecretory drugs.
    Takada M; Fukumoto K; Shibakawa M
    J Clin Pharm Ther; 2004 Apr; 29(2):183-7. PubMed ID: 15068408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gastric hemorrhage caused by acetylsalicylic acid--a comparison of soluble and buffered preparations].
    Isomäki H; von Essen R
    Lakartidningen; 1975 Apr; 72(15):1561-2. PubMed ID: 1079553
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of serum salicylate levels and gastro-intestinal blood loss between salsalate (Disalcid)and other forms of salicylates.
    Mielants H; Veys EM; Verbruggen G; Schelstraete
    Scand J Rheumatol; 1981; 10(3):169-73. PubMed ID: 7027430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative bioavailability of aspirin from buffered, enteric-coated and plain preparations.
    Latini R; Cerletti C; de Gaetano G; Dejana E; Galletti F; Urso R; Marzot M
    Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):313-8. PubMed ID: 3733281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of omeprazole with enteric-coated salicylate tablets.
    Nefesoglu FZ; Ayanoglu-Dülger G; Ulusoy NB; Imeryüz N
    Int J Clin Pharmacol Ther; 1998 Oct; 36(10):549-53. PubMed ID: 9799060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product.
    Kelly JP; Kaufman DW; Jurgelon JM; Sheehan J; Koff RS; Shapiro S
    Lancet; 1996 Nov; 348(9039):1413-6. PubMed ID: 8937281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of enteric coating of aspirin tablets on occult gastrointestinal blood loss.
    Howe GB; Champion GD; Corrigan AB; Hewson J; Haski A; Day RO; Paull PD; Graham GG
    Aust N Z J Med; 1977 Dec; 7(6):600-4. PubMed ID: 350214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopic evaluation of the effects of aspirin, buffered aspirin, and enteric-coated aspirin on gastric and duodenal mucosa.
    Lanza FL; Royer GL; Nelson RS
    N Engl J Med; 1980 Jul; 303(3):136-8. PubMed ID: 6966762
    [No Abstract]   [Full Text] [Related]  

  • 14. [Analgesics; the use of aspirin in dogs; effects of tablet type and food intake on plasma salicylate level].
    Nap RC; Breen DJ; Lam TJ; Peters IO; Willemsen A; De Bruyne JJ
    Tijdschr Diergeneeskd; 1993 Jul; 118(13):439-42. PubMed ID: 8346511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salicylates in the management of rheumatoid arthritis.
    Pinals RS
    Mod Treat; 1971 Nov; 8(4):796-806. PubMed ID: 5316723
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of different aspirin formulations on platelet aggregation times and on plasma salicylate concentrations.
    Schwertner HA; McGlasson D; Christopher M; Bush AC
    Thromb Res; 2006; 118(4):529-34. PubMed ID: 16298420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acetylsalicylic acid and gastrointestinal bleeding--a study of blood loss and absorption after intake of a gastric juice--resistant preparation].
    Arvidsson B; Magnusson A; Magnusson B; Sölvell L
    Lakartidningen; 1977 Nov; 74(46):4101-2. PubMed ID: 337007
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparison of enteric-coated aspirin granules with plain and buffered aspirin: a report of two studies.
    Petroski D
    Am J Gastroenterol; 1986 Jan; 81(1):26-8. PubMed ID: 3942122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Difference in risk of gastrointestinal complications between users of enteric-coated and buffered low-dose aspirin.
    Takada M; Fujimoto M; Hosomi K
    Int J Clin Pharmacol Ther; 2014 Mar; 52(3):181-91. PubMed ID: 24472400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetylsalicylic acid and gastrointestinal bleeding measurement of blood loss using a modified radioactive chromium method.
    Arvidsson B; Magnusson B; Sölvell ; Magnusson A
    Scand J Gastroenterol; 1975; 10(2):155-60. PubMed ID: 1091965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.